Meta Ad Library Scraping — Legal, Ethical, What Agencies Actually Do in 2026

Twice a month, an agency founder asks me the same question in some variation: "Is it legal to scrape Meta Ad Library? Our team is doing it manually with a spreadsheet and we want to automate it — but nobody wants to end up on the wrong side of Meta's terms." The honest answer is not a yes or a no. It is a set of lines that most Indian healthcare agencies do not know exist, and a set of practices that stay well inside them.

This is written for agency owners, in-house marketing leads, and any team building competitive intelligence workflows around public ad data. It is not legal advice — get your own lawyer if you are about to invest six figures in a scraping stack. But it is the operating framework Prism Spy was built inside, and it reflects what serious healthcare agencies in India do in 2026.

What Meta actually says versus what the internet claims Meta says

The internet claims two contradictory things: that Meta strictly forbids all scraping of Ad Library, and that Ad Library is fully open data anyone can do anything with. Both are wrong.

Meta's Terms of Service prohibit automated collection of data from Meta properties without prior written consent. The Ad Library sits inside that same terms surface. Meta has, on several public record occasions, sent cease-and-desist letters to firms running heavy automated crawlers against Ad Library, particularly firms scraping millions of records per day to resell into a commercial data product. Meta has also, on the other hand, taken almost no public enforcement action against low-frequency human-assisted collection or against academic and journalistic research programs that pull data at reasonable rates.

What sits in the middle — a healthcare agency checking a watchlist of 30 to 75 competitor brands once every 24 hours — is a grey zone in Meta's own enforcement posture. Meta clearly does not want you spinning up a distributed crawler farm. Meta has never publicly enforced against agencies pulling their competitors' public ads at human-scale frequency for legitimate competitive research. Prism Spy operates in that middle zone by design.

The four principles serious agencies operate by

Every agency in India running competitor Meta Ads research at scale — whether homebuilt or through a platform like Prism Spy — should operate by four self-imposed principles. These are what keep you out of Meta's enforcement path and what keep you compliant with Indian data laws.

1. Public sources only. Meta Ad Library, Google Ads Transparency Centre, brand landing pages, and public social profiles. No authenticated dashboards. No private CRM data. No data from tools that require you to log in to a competitor's own admin surface. If you cannot access it without an account, it is off-limits.
2. Human-scale request rates. A watchlist of 75 brands checked once every 24 hours generates roughly 75 requests per day against Meta. That is well below what a single manual analyst opening browser tabs would generate over the same period. If your rate would raise eyebrows on a Meta abuse dashboard, it is too fast.
3. No republishing of Meta's raw dataset. Meta objects to firms rehosting Ad Library data as a commercial product for third-party sale. Aggregating it internally, analysing it, and surfacing insights to your own client for their own competitive research is a different activity. Reselling the raw dump would cross the line.
4. DPDP-clean. India's Digital Personal Data Protection Act 2023 governs personal data of Indian residents. Meta Ad Library data is corporate advertising disclosure — not personal data of any individual. That said, if your workflow ever bumps into individual doctor names, patient photographs, or user reviews, DPDP obligations attach. Keep the two data streams separate.

What Indian healthcare agencies actually do

Meta Catalyst IQ Master Dashboard showing account-level KPIs, spend, CPQL and campaign health for a healthcare Meta Ads account" width="1200" height="675" loading="lazy" decoding="async" style="width:100%;height:auto;display:block;">

In practice, the healthcare agencies I see running the sharpest competitive intelligence fall into three camps. The first camp runs everything manually — an analyst opens Ad Library every Monday, screenshots the watchlist brand by brand, drops it into a shared drive. Slow but legally bulletproof. Works for agencies with fewer than 15 brands on the watchlist.

The second camp built a small internal automation — a Python script or a n8n workflow that pings Ad Library on a schedule and dumps the results into an Airtable or Notion base. Faster than manual. Legally fine if kept internal, at human-scale rates, and with the four principles above intact. The problem is engineering upkeep: Meta refactors Ad Library HTML every few months and the scraper breaks. Most agencies in this camp lose their tool inside 18 months.

The third camp uses a purpose-built platform (Prism Spy, or one of the horizontal competitors). Same underlying legal posture as camp two — public data, human-scale rates, no republishing. But the engineering burden is on the platform, not the agency. The intelligence layer (killed-ad history, quality scoring, offer surveillance) is what you pay for, not just the fetch pipeline.

Where scraping crosses into territory to avoid

Some workflows I have seen in the wild that I would not touch:

• Scraping the checkout funnel of a competitor's landing page to time offer changes to the minute. Public landing pages are fair game to read once; hammering them at the rate needed to catch minute-level changes is DoS-adjacent.
• Building a login-required scraper against a competitor's Meta Business Manager, LinkedIn Sales Navigator, or any other authenticated surface. This crosses from "public research" into unauthorised access under Section 43 of the Indian IT Act.
• Scraping user reviews from Google Business Profile or Practo to build a personal-data database about specific doctors or clinics. That is DPDP-regulated personal data with named data subjects.
• Purchasing scraped ad data from third-party resellers who cannot document their collection methodology. If your vendor cannot answer the four-principles checklist above, their liability becomes your liability.

Legal versus ethical is not the same conversation

A workflow can be legal and still worth avoiding on ethical grounds. Aggregating a competitor's public ad creative to reverse-engineer their offer structure is legal and, in my view, ethically fine — you are learning from disclosure that was deliberately made public. Aggregating the same competitor's employee LinkedIn posts to profile their internal team churn is legal in the strict sense but crosses into surveillance behaviour that most healthcare agencies I respect would not do to a peer.

The test I apply personally, and the one Meta Catalyst IQ and Prism Spy are both built inside: if a competitor found out what you were doing tomorrow, would you be embarrassed? Public ad research passes that test easily. Building a scraper against their booking funnel does not. Draw your own line, but draw it consciously.

What Prism Spy commits to publicly

For the record, and so agencies evaluating the platform know exactly what they are buying: Prism Spy only aggregates data from Meta Ad Library (public), Google Ads Transparency Centre (public), and brand landing pages (public, read at human-scale rates). No authenticated data sources. No DPDP-regulated personal data. No republishing of raw Meta datasets to third parties. Same legal and ethical footing as a competitive research analyst with a browser and a spreadsheet, just with better memory and better ranking. If you want to see the exact compliance posture in writing before you sign, that document sits inside the ICG healthcare social media agency engagement contracts and is available on request.

Frequently asked